Future Capital

Ekuaibao is a developer of an online enterprise consumption and reimbursement management platform tailored for corporate clients. The company focuses on managing corporate claims and expenses, offering services that include professional ordering, cost control, and reimbursement management. Its platform is designed to assist organizations in efficiently handling employee cost reimbursements, business travel planning, and other cost management operations. By providing innovative invoice management solutions, Ekuaibao aims to help companies reduce operational costs and enhance overall efficiency.

Megarobo is an AI and robotics company established in 2016 and headquartered in Beijing, China. It specializes in developing collaborative robots and advanced automation solutions tailored for life sciences, clinical diagnosis, and applied chemistry. By focusing on integrating robotics and artificial intelligence into industry applications, Megarobo aims to enhance research efficiency for life science companies and scientific research institutions. The company is dedicated to providing flexible and practical automation products that streamline laboratory services, ultimately driving innovation in the field of scientific research.

Duckbill provides container trucking transportation services, international freight forwarding, and warehousing services by using big data and AI.

Bishi Technology is a tech enterprise in the field of intelligent operation and maintenance, Biztech has always been committed to providing enterprise users with easy-to-use and stable intelligent operation and maintenance products. Biz intelligent operation and maintenance platform is based on machine learning algorithms, helping large enterprise data centers to find faults in advance, locate fault ranges, predict trends in massive monitoring data, reduce mean time to repair (MTTR) and prolong system trouble-free running time (MTBF) , improve system availability and operation and maintenance efficiency.

Duckbill provides container trucking transportation services, international freight forwarding, and warehousing services by using big data and AI.

Aignostics GmbH is a Berlin-based company founded in 2018 that specializes in AI-powered diagnostics and pathology software solutions aimed at enhancing pharmaceutical research and clinical diagnostics. The company focuses on precision diagnostics, employing patented technology to reverse-engineer conventional AI systems, thereby addressing their “black-box” limitations. Aignostics' platform generates explainable diagnostic results presented as precise heatmaps and image overlays, which facilitate the verification process for pathologists. This capability is crucial in ensuring accurate diagnoses, particularly in the context of discovering and validating biomarkers for cancer and other complex diseases. By improving the understanding of tissue-based biomarkers, Aignostics aims to significantly advance the diagnosis and treatment of various conditions, thereby supporting the broader goals of precision medicine and drug development.

ClickPaaS is a provider of low code development platform products and solutions based on hpaPaaS that helps SaaS enterprises, consulting firms, and enterprise customers to significantly reduce response times and costs for complex business requirements. ClickPaaS is an innovative technology platform company dedicated to the development and service of the highly productive aPaaS platform, providing fast, high-quality technology platforms for government companies, consulting companies, startups and professional partners.

Ruixun Biotech is a healthcare company that provides biotechnology. Ruixun Biotech combines microfluidics, optics, precision instruments, electronic engineering, and biochemical technologies to create upstream equipment and consumables for molecular diagnosis and genetic testing. They released a number of products, including the digital PCR apparatus DropX-2000 and more than 50 different RUO detection kits.

RainSure Scientific is a medical-based manufacturing company that produces PCR instruments, assays, and healthcare services.

Li Auto Inc. is a prominent Chinese manufacturer of smart electric vehicles, specializing in the design, development, production, and sale of premium electric sport utility vehicles (SUVs). Established in 2015 and headquartered in Beijing, the company launched its first model, the Li ONE, in November 2019. This six-seat electric SUV features a range extension system and advanced smart vehicle solutions, catering to consumers seeking longer travel capabilities. In 2023, Li Auto sold over 376,000 new energy vehicles, capturing approximately 4% of China's passenger new energy vehicle market. The company continues to expand its product offerings, including battery electric vehicles (BEVs) and plug-in hybrid electric vehicles (PHEVs), in order to reach a wider audience and meet diverse consumer needs.

Zvision provides automotive-grade solid-state LiDAR solution for autonomous driving applications. The company's first-generation laser radar products use MEMS technology, and plan to achieve scale-up in the L3-class autonomous driving and unmanned logistics fields in the next five years, and layout the next generation optical-based phased array (OPA) through its integrated chip research and development capabilities. The technical laser radar is aimed at the L4/L5 level autopilot market after 5-10 years.

Miss Evan is a prominent secondary audio community that specializes in pop culture entertainment. The company offers a social platform for designers and artists to share and distribute a diverse range of 2D media, including audio comic series, live broadcasts, original music, audiobooks, and ringtone designs. By fostering a creative environment, Miss Evan connects creators with audiences, enhancing the experience of consuming and interacting with various forms of entertainment.

Yihang.ai specializes in developing autonomous driving systems for automobiles. Founded in 2015 with headquarters in Beijing, China, the company offers AutoPilot, a comprehensive driverless solution utilizing algorithms, machine learning, and artificial intelligence to enhance safety and reduce driver burden.

Nongfenqi is a rural internet finance services platform operated by Nanjing Nongfenqi E-Commerce Co. Ltd. The company specializes in offering installment payment services specifically tailored for large farming groups and collaborative communes, facilitating their purchases of agricultural equipment. By doing so, Nongfenqi aims to support farmers in cultivating crops more efficiently. To date, the company has successfully served approximately 20,000 clients, contributing to the transformation of agricultural financing in rural areas.

Ganymed Pharmaceuticals AG is a biopharmaceutical company with the mission of revolutionizing cancer treatment by developing a new class of therapeutic drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues. They can thus be administered at optimal dose and have a broad therapeutic window with reduced risks of side effects.

Ganymed Pharmaceuticals AG is a biopharmaceutical company with the mission of revolutionizing cancer treatment by developing a new class of therapeutic drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues. They can thus be administered at optimal dose and have a broad therapeutic window with reduced risks of side effects.

Ganymed Pharmaceuticals AG is a biopharmaceutical company with the mission of revolutionizing cancer treatment by developing a new class of therapeutic drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues. They can thus be administered at optimal dose and have a broad therapeutic window with reduced risks of side effects.

Ganymed Pharmaceuticals AG is a biopharmaceutical company with the mission of revolutionizing cancer treatment by developing a new class of therapeutic drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues. They can thus be administered at optimal dose and have a broad therapeutic window with reduced risks of side effects.

3-G International is a software development company specializing in smart card, biometric, and card management solutions. Founded in 1982 and headquartered in Springfield, Virginia, the company focuses on creating advanced security products for the internet and network security sectors. Its offerings enhance authentication processes and provide businesses with more secure methods for accessing workstations, networks, and applications compared to traditional password systems. Through its innovative technology, 3-G International aims to meet the growing demands for more robust security measures in various industries, particularly in e-commerce and authentication.